Showing results (131-140 of 302) with videos related to
Sort By:
Pageof 31
Cancer Prevention Research (Philadelphia, Pa.)|August 3, 2017
In Silico Systems Biology Analysis of Variants of Uncertain Significance in Lynch Syndrome Supports the Prioritization of Functional Molecular ValidationEster Borras, Kyle Chang, Mala Pande, et al.International Journal of Radiation Oncology, Biology, Physics|March 24, 2007
Predictors and patterns of recurrence after definitive chemoradiation for anal cancerPrajnan Das, Sumita Bhatia, Cathy Eng, et al.American Journal of Clinical Oncology|June 7, 2006
Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival?Edward H Lin, Steven A Curley, Christopher C Crane, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2012
Neoadjuvant treatment response as an early response indicator for patients with rectal cancerIn Ja Park, Y Nancy You, Atin Agarwal, et al.Cancer Genetics|November 30, 2014
Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancerEduardo Vilar, Maureen E Mork, Amanda Cuddy, et al.Diseases of the Colon and Rectum|January 5, 2006
Outcome after curative resection for locally recurrent rectal cancerIsabelle Bedrosian, Geoffrey Giacco, Lee Pederson, et al.International Journal of Radiation Oncology, Biology, Physics|January 17, 2009
Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: incidence, risk factors, and clinical courseMichael P Herman, Scott Kopetz, Priya R Bhosale, et al.Cancer|August 2, 2016
Comparative effectiveness of primary tumor resection in patients with stage IV colon cancerZeinab Alawadi, Uma R Phatak, Chung-Yuan Hu, et al.Cancer Medicine|October 18, 2013
Metformin use and improved response to therapy in rectal cancerHeath D Skinner, Christopher H Crane, Christopher R Garrett, et al.Annals of Surgery|October 21, 2020
Acellular Dermal Matrix Provides Durable Long-Term Outcomes in Abdominal Wall Reconstruction: A Study of Patients with Over 60 Months of Follow-upMalke Asaad, Sahil K Kapur, Donald P Baumann, et al.Pageof 31